# Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

> **NCT01233479** · NA · WITHDRAWN · sponsor: **Pediatric Brain Tumor Consortium**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** systemic chemotherapy
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** therapeutic surgical procedure
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01233479
- **Lead sponsor:** Pediatric Brain Tumor Consortium
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05
- **Primary completion:** 2011-07
- **Final completion:** 2017-08-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This non-therapeutic study was registered in error. The PRS team doesn't delete studies once registered, so they recommended changing the status to Withdrawn
- **Last updated:** 2019-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233479, "Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01233479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*